A limitation of this study is that it did not provide clinical data of patients with lactotroph PitNETs and did not examine the putative association between PPARγ expression and clinical parameters, such as tumor size, plasma prolactin levels, survival, and relapse; therefore, it would be highly relevant to study these aspects in future studies. The gene discussed is PPARG; the disease is neoplasm.